Tissue DonorsKidney TransplantationLiving DonorsBlood DonorsTransplantsGraft RejectionGraft SurvivalTransplantation, HomologousImmunosuppressive AgentsHeart TransplantationTransplantationTissue and Organ ProcurementLung TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTreatment OutcomeHistocompatibility TestingCyclosporineTacrolimusTime FactorsWaiting ListsPostoperative ComplicationsRetrospective StudiesImmunosuppressionCadaverGraft vs Host DiseaseCytomegalovirus InfectionsTransplantation ImmunologyFetal Tissue TransplantationMycophenolic AcidLiver FailureHistocompatibilityKidney Failure, ChronicImmunocompromised HostTransplantation ConditioningFollow-Up StudiesRisk FactorsHLA AntigensBrain DeathHeart-Lung TransplantationTransplantation, AutologousTransplantation ToleranceTransplantation, HeterotopicBrain Tissue TransplantationTissue and Organ HarvestingBronchiolitis ObliteransIsoantibodiesRecurrenceCytomegalovirusHematologic NeoplasmsSurvival AnalysisSurvival RateAntilymphocyte SerumDirected Tissue DonationKidneyOpportunistic InfectionsBiopsyTransplantation, IsogeneicBK VirusProspective StudiesLiver DiseasesIslets of Langerhans TransplantationGanciclovirLiver TransplantationEnd Stage Liver DiseaseLymphoproliferative DisordersWhole-Body IrradiationCreatinineAcute DiseaseCorneal TransplantationPrimary Graft DysfunctionPolyomavirus InfectionsIncidenceSkin TransplantationPostoperative PeriodKidney DiseasesStem Cell TransplantationT-LymphocytesLeukemiaCord Blood Stem Cell TransplantationDeathBlood Group IncompatibilityPatient SelectionCold IschemiaFatal OutcomeMycosesAntiviral AgentsCohort StudiesBlood TransfusionPrognosisRegistriesAnemia, AplasticTissue TransplantationInfectionSirolimusPolymerase Chain ReactionMice, Inbred C57BLRisk AssessmentKaplan-Meier EstimateCell Transplantation